Physicians and healthcare providers can attend the instructor course of TAI Chi now available at the conference. Dr AJ Farshchian held classes for Physicians.

Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into Ulisse Biomed via a reverse take-over transaction. The new group, strong of flawless interoperability between its leading technologies, aims to become a new benchmark of innovation in the national and international biotech market.

Partnership extends capability for trial imaging integration to Florence Healthcare’s 18,000 activated clinical trial sites.

The new board and leadership appointment aligns with the company’s commitment to advancing the industry through innovation and the expansion of AI across its solutions

Investment will further accelerate company growth and innovation across all services and offerings

Rigorous Audit Validates Auxilius as a Trusted Clinical Trial Financial Management Platform, a Key Element of Compliance and Assurance of Controls for the Highly Regulated Life Sciences Industry

Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.

Sapio LIMS/ELN Provides NatureMetrics With a Configurable Workflow and Data Solution That Adapts as eDNA Technology Rapidly Evolves

Fast and efficient labeling solution for life sciences releases new generation of inkjet direct printer to facilitate scientific discovery.

Research is currently underway to develop Cystic Fibrosis treatments

The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human heart models

Pivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

The pioneer of ingredients created using sustainable biotech joins over 60 other member companies, all working to advocate for a responsible, sustainable fragrance industry

The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders.

Expert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness.

Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators

The First and Only Deep Tissue Negative Pressure Therapy Device Platform

Together the two companies will expand their reach and capabilities to better serve the Pharma and Biotech Industries

P23 gives back regularly throughout the year, starting in January, with efforts ranging from monetary donations to back-to-school drives as a symbol to its social responsibility centered around the 23rd of each month and ending with the 23 Days of Giving in December

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.

Nation's largest reseller and service company of certified pre-owned automation and imaging lab equipment acquires Atlantic Lab Equipment of Beverly, Ma.

Integrated QC dashboard and unlimited validation cycles for interim and final datasets creates industry's most user-friendly validator

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

ZetrOZ Systems' musculoskeletal ultrasound device facilitates return to regular activities

Let Spora Biotech introduce you to a new era of textiles made from mushrooms.

Medtech, Biotech, and Pharma industries will gather for the Medtech A+ Team - how to do a successful RegA+ for a Medtech company in a different format, with quicker panels and more information